<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Wang Z</submitter><funding>National Center for Advancing Translational Sciences</funding><funding>NCATS NIH HHS</funding><funding>Howard Hughes Medical Institute</funding><funding>NIAID NIH HHS</funding><funding>National Institutes of Health</funding><funding>Rockefeller University</funding><pagination>e20221006</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9513381</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>219(12)</volume><pubmed_abstract>Individuals who receive a third mRNA vaccine dose show enhanced protection against severe COVID-19, but little is known about the impact of breakthrough infections on memory responses. Here, we examine the memory antibodies that develop after a third or fourth antigenic exposure by Delta or Omicron BA.1 infection, respectively. A third exposure to antigen by Delta breakthrough increases the number of memory B cells that produce antibodies with comparable potency and breadth to a third mRNA vaccine dose. A fourth antigenic exposure with Omicron BA.1 infection increased variant-specific plasma antibody and memory B cell responses. However, the fourth exposure did not increase the overall frequency of memory B cells or their general potency or breadth compared to a third mRNA vaccine dose. In</pubmed_abstract><journal>The Journal of experimental medicine</journal><pubmed_title>Memory B cell responses to Omicron subvariants after SARS-CoV-2 mRNA breakthrough infection in humans.</pubmed_title><pmcid>PMC9513381</pmcid><funding_grant_id>P01 AI165075</funding_grant_id><funding_grant_id>U19 AI111825</funding_grant_id><funding_grant_id>P01 AI138938</funding_grant_id><funding_grant_id>R37-AI64003</funding_grant_id><funding_grant_id>P01-AI138398-S1</funding_grant_id><funding_grant_id>R01AI78788</funding_grant_id><funding_grant_id>UL1 TR001866</funding_grant_id><funding_grant_id>R01 AI078788</funding_grant_id><funding_grant_id>2U19AI111825</funding_grant_id><funding_grant_id>R37 AI064003</funding_grant_id><funding_grant_id>P01AI165075</funding_grant_id><pubmed_authors>Canis M</pubmed_authors><pubmed_authors>Kaczynska A</pubmed_authors><pubmed_authors>Ben Tanfous T</pubmed_authors><pubmed_authors>Dizon J</pubmed_authors><pubmed_authors>Gazumyan A</pubmed_authors><pubmed_authors>Nussenzweig MC</pubmed_authors><pubmed_authors>Millard KG</pubmed_authors><pubmed_authors>Schmidt F</pubmed_authors><pubmed_authors>Cho A</pubmed_authors><pubmed_authors>Caskey M</pubmed_authors><pubmed_authors>Muecksch F</pubmed_authors><pubmed_authors>Da Silva J</pubmed_authors><pubmed_authors>Johnson B</pubmed_authors><pubmed_authors>Witte L</pubmed_authors><pubmed_authors>Wang Z</pubmed_authors><pubmed_authors>Shimeliovich I</pubmed_authors><pubmed_authors>Bednarski E</pubmed_authors><pubmed_authors>Ramos V</pubmed_authors><pubmed_authors>Zong S</pubmed_authors><pubmed_authors>Hatziioannou T</pubmed_authors><pubmed_authors>Zhou P</pubmed_authors><pubmed_authors>Raspe R</pubmed_authors><pubmed_authors>Turroja M</pubmed_authors><pubmed_authors>Oliveira TY</pubmed_authors><pubmed_authors>Bieniasz PD</pubmed_authors><pubmed_authors>Gaebler C</pubmed_authors><pubmed_authors>Jankovic M</pubmed_authors><pubmed_authors>Yao KH</pubmed_authors></additional><is_claimable>false</is_claimable><name>Memory B cell responses to Omicron subvariants after SARS-CoV-2 mRNA breakthrough infection in humans.</name><description>Individuals who receive a third mRNA vaccine dose show enhanced protection against severe COVID-19, but little is known about the impact of breakthrough infections on memory responses. Here, we examine the memory antibodies that develop after a third or fourth antigenic exposure by Delta or Omicron BA.1 infection, respectively. A third exposure to antigen by Delta breakthrough increases the number of memory B cells that produce antibodies with comparable potency and breadth to a third mRNA vaccine dose. A fourth antigenic exposure with Omicron BA.1 infection increased variant-specific plasma antibody and memory B cell responses. However, the fourth exposure did not increase the overall frequency of memory B cells or their general potency or breadth compared to a third mRNA vaccine dose. In</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Dec</publication><modification>2026-04-08T11:57:56.319Z</modification><creation>2024-11-12T00:22:50.359Z</creation></dates><accession>S-EPMC9513381</accession><cross_references><pubmed>36149398</pubmed><doi>10.1084/jem.20221006</doi></cross_references></HashMap>